EA201991180A1 - Новые фенильные производные - Google Patents
Новые фенильные производныеInfo
- Publication number
- EA201991180A1 EA201991180A1 EA201991180A EA201991180A EA201991180A1 EA 201991180 A1 EA201991180 A1 EA 201991180A1 EA 201991180 A EA201991180 A EA 201991180A EA 201991180 A EA201991180 A EA 201991180A EA 201991180 A1 EA201991180 A1 EA 201991180A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- new
- fenily
- derivatives
- methyl
- diabetes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
В настоящей заявке предложено новое фенильное производное 5-[(2,4-динитрофенокси)метил]-1-метил-2-нитро-1H-имидазол или его фармацевтически приемлемая соль, которые можно применять для регулирования активности митохондрий, снижения ожирения, лечения заболеваний, включая диабет и осложнения, связанные с диабетом.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762585326P | 2017-11-13 | 2017-11-13 | |
PCT/US2018/012491 WO2018129258A1 (en) | 2017-01-06 | 2018-01-05 | Novel phenyl derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201991180A1 true EA201991180A1 (ru) | 2019-11-29 |
Family
ID=68653627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201991180A EA201991180A1 (ru) | 2017-11-13 | 2018-01-05 | Новые фенильные производные |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA201991180A1 (ru) |
-
2018
- 2018-01-05 EA EA201991180A patent/EA201991180A1/ru unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019001842A1 (es) | Nuevos derivados de fenilo. | |
EP4331677A3 (en) | Methods of treating feline coronavirus infections | |
PH12017550004B1 (en) | Heterocyclic derivatives and use thereof | |
CL2019003126A1 (es) | Métodos de tratamiento mediante el uso de un compuesto inhibidor de jak. | |
MX367554B (es) | Derivados heterocíclicos y sus usos. | |
EA201890594A1 (ru) | Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний | |
EA201790785A1 (ru) | Производные тетрагидроизохинолина | |
EA201691624A1 (ru) | Гетероциклическое соединение | |
EA201500953A1 (ru) | 3-ацетиламино-1-(фенилгетероариламинокарбонил или фенилгетероарилкарбониламино)бензольные производные для лечения гиперпролиферативных нарушений | |
EA201790660A1 (ru) | Ингибитор киназ | |
CY1119118T1 (el) | Θεραπευτικος παραγων για τις διαταραχες της διαθεσης | |
EA201891377A1 (ru) | ПРИМЕНЕНИЕ МОДУЛЯТОРОВ КАНАЛОВ Kv3.1/Kv3.2/Kv3.3 ДЛЯ ЛЕЧЕНИЯ БОЛИ | |
EA201591391A1 (ru) | Производное 2-ациламинотиазола или его соль | |
EA201992306A1 (ru) | Ингибиторы ip6k | |
CY1119483T1 (el) | Θεραπευτικος παραγων για τις αγχωδεις διαταραχες | |
EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
BR112019018028A2 (pt) | Composto, combinação, e. uso de um composto ou um sal farmaceuticamente aceitável do mesmo | |
EA201991180A1 (ru) | Новые фенильные производные | |
CL2020000586A1 (es) | Moduladores de la expresión de enac. | |
EA201792670A1 (ru) | Производные 2-(1-гетероарилпиперазин-4-ил)метил-1,4- бензодиоксана в качестве альфа2c-антагонистов | |
MX2016011310A (es) | Agente para el control de endoparasitos. | |
EA201690236A1 (ru) | Производные индол-3-карбинола | |
MX2021004811A (es) | Uso conjunto de un compuesto a y un compuesto b en la preparacion de medicamentos para el tratamiento de gota o hiperuricemia. | |
AR119036A1 (es) | Compuestos de imidazolio mesoiónico y derivados para combatir plagas de animales | |
EA202190247A1 (ru) | ПРИМЕНЕНИЕ рГЦ СТИМУЛЯТОРОВ ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ |